RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 69 filers reported holding RAPT THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $706,668 | -13.3% | 42,520 | -2.5% | 0.00% | 0.0% |
| Q2 2023 | $815,114 | +106311.7% | 43,589 | +4.4% | 0.00% | 0.0% |
| Q1 2023 | $766 | +9.1% | 41,769 | +17.8% | 0.00% | 0.0% |
| Q4 2022 | $702 | -99.9% | 35,465 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $835,000 | +42.7% | 34,690 | +8.3% | 0.00% | 0.0% |
| Q2 2022 | $585,000 | +21.1% | 32,038 | +45.9% | 0.00% | 0.0% |
| Q1 2022 | $483,000 | -29.2% | 21,961 | +18.3% | 0.00% | 0.0% |
| Q4 2021 | $682,000 | +29.9% | 18,556 | +9.8% | 0.00% | 0.0% |
| Q3 2021 | $525,000 | +4.6% | 16,897 | +6.9% | 0.00% | 0.0% |
| Q2 2021 | $502,000 | +118.3% | 15,799 | +52.6% | 0.00% | – |
| Q1 2021 | $230,000 | +4.1% | 10,350 | -7.6% | 0.00% | – |
| Q4 2020 | $221,000 | -31.2% | 11,200 | +12.4% | 0.00% | -100.0% |
| Q3 2020 | $321,000 | -7.0% | 9,967 | -16.2% | 0.00% | 0.0% |
| Q2 2020 | $345,000 | – | 11,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
| KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
| Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
| Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
| Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
| AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
| Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
| Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |